One fingerstick, three infections: new rapid test under study

NCT ID NCT07569913

Not yet recruiting Diagnosis Sponsor: bioLytical Laboratories Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new rapid device called TruPlex that checks for HIV, Hepatitis B, and Syphilis using a single fingerstick blood sample. About 500 adults at risk for these infections will take part. Researchers want to see if the test is accurate and easy for trained staff to use at clinics or point-of-care sites.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TruPlex HIV/HepB/Syphilis Rapid Test (a rapid diagnostic device using a fingerstick blood sample)
What this could lead to: If successful, this could provide a fast, single-test way to detect three infections at once, making screening easier in clinics and community settings.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The test may not be as accurate as current lab methods, and results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS B INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatitis B virus infection HIV infectious disease syphilis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATITIS B INFECTION HIV 2 INFECTION HIV1 INFECTION SYPHILIS INFECTION

Contacts and locations

Locations

St Vincent's Hospital (Melbourne), Dept. of Gastroenterology

Melbourne, Victoria, 3065, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.